Adverse outcome pathway (AOP) -informed tiered testing to predict developmental or reproductive toxicity (DART) risks during new active substance R&D. (10th October 2018) - Currie, R.; Delany, J.; Kidley, N.; Papachristos, K.; Wolton, K.; Cowie, D.; Richards-Doran, R.; Wang, S.; Modi, S.